MENU

Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ:SCNI)

0.2425 +0.0025 (+1.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 121,923
Open 0.2400
Bid (Size) 0.2260 (9,000)
Ask (Size) 0.2377 (2,000)
Prev. Close 0.2400
Today's Range 0.2400 - 0.2498
52wk Range 0.2147 - 1.960
Shares Outstanding 461,285,824
Dividend Yield N/A

Performance

YTD
-66.8%
-66.8%
1 Month
-7.8%
-7.8%
3 Month
-54.8%
-54.8%
6 Month
-67.4%
-67.4%
1 Year
-86.7%
-86.7%

More News

Read More

Frequently Asked Questions

Is Scinai Immunotherapeutics Ltd. - American Depositary Shares publicly traded?
Yes, Scinai Immunotherapeutics Ltd. - American Depositary Shares is publicly traded.
What exchange does Scinai Immunotherapeutics Ltd. - American Depositary Shares trade on?
Scinai Immunotherapeutics Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The ticker symbol for Scinai Immunotherapeutics Ltd. - American Depositary Shares is SCNI on the Nasdaq Stock Market
What is the current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The current price of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 0.2425
When was Scinai Immunotherapeutics Ltd. - American Depositary Shares last traded?
The last trade of Scinai Immunotherapeutics Ltd. - American Depositary Shares was at 08/14/26 04:00 PM ET
What is the market capitalization of Scinai Immunotherapeutics Ltd. - American Depositary Shares?
The market capitalization of Scinai Immunotherapeutics Ltd. - American Depositary Shares is 111.86M
How many shares of Scinai Immunotherapeutics Ltd. - American Depositary Shares are outstanding?
Scinai Immunotherapeutics Ltd. - American Depositary Shares has 112M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
TOP
Email a Story